The subsequent acquisition of subclonal driver mutations, including the chromatin regulators PBRM1, SETD2 and BAP1, culminates in the establishment of overt ccRCC tumours8–10. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.